Daniel P. O'Day - Mar 1, 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chairman & CEO, Director
Signature
/s/ Amy Kim by Power of Attorney for Daniel O'Day
Stock symbol
GILD
Transactions as of
Mar 1, 2023
Transactions value $
-$385,375
Form type
4
Date filed
3/2/2023, 05:48 PM
Previous filing
Jan 26, 2023
Next filing
Mar 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +11.4K +3.22% 364K Mar 1, 2023 Direct F1
transaction GILD Common Stock Tax liability -$385K -4.84K -1.33% $79.59 359K Mar 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -11.4K -8.92% 116K Mar 1, 2023 Common Stock 11.4K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.